Jill L. Ostrem

Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial

William J. Marks, Raymond T. Bartus, João Siffert et al. · The Lancet Neurology · 2010 · 680 citations

Life Sciences, Neurology, Neuroscience +12

Therapeutic deep brain stimulation reduces cortical phase-amplitude coupling in Parkinson's disease

Coralie de Hemptinne, Nicole C. Swann, Jill L. Ostrem et al. · Nature Neuroscience · 2015 · 646 citations · Full text

Life Sciences, Neurology, Neuroscience +14

Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial

William J. Marks, Jill L. Ostrem, L. Verhagen et al. · The Lancet Neurology · 2008 · 587 citations

Medicine, Neurology, Pharmacology +11

Exaggerated phase–amplitude coupling in the primary motor cortex in Parkinson disease

Coralie de Hemptinne, Elena Ryapolova-Webb, Ellen L. Air et al. · Proceedings of the National Academy of Sciences · 2013 · 571 citations · Full text

Life Sciences, Neuroscience, Neurosurgery +17

Randomized trial of deep brain stimulation for Parkinson disease

Frances M. Weaver, Kenneth A. Follett, Matthew Stern et al. · Neurology · 2012 · 443 citations · Full text

Medicine, Neurological Surgery, Neurology +17